Metraipolis › archive › dc_84ebf7e4494c
Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly — Europe PMC PMID:31622442
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31622442
- DOI
- 10.1371/journal.ppat.1008078
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-10T07:35:47.322Z
- SHA-256 of the archived text
7bd6f6b0bb32d2b0da7f419ff7e94df7f306a596f7739a49b86635069c7c0f2b- Stable URL of this page
https://metraipolis.com/documento/dc_84ebf7e4494c
How to cite
Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly — Europe PMC PMID:31622442 — Europe PMC (en), https://europepmc.org/article/MED/31622442 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_84ebf7e4494c (Metraipolis archive dc_84ebf7e4494c, sha256 7bd6f6b0bb32d2b0da7f419ff7e94df7f306a596f7739a49b86635069c7c0f2b)
BibTeX
@misc{dc84ebf7e4494c,
title = {Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly — Europe PMC PMID:31622442},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31622442},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_84ebf7e4494c; sha256 7bd6f6b0bb32d2b0da7f419ff7e94df7f306a596f7739a49b86635069c7c0f2b},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31622442. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
The antibiotic, fosmidomycin (FSM) targets the methylerythritol phosphate (MEP) pathway of isoprenoid synthesis by inhibiting the essential enzyme, 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr) and is lethal to intracellular parasites and bacteria. The obligate intracellular bacterial pathogen, Chlamydia trachomatis, alternates between two developmental forms: the extracellular, infectious elementary body (EB), and the intracellular, replicative form called the reticulate body (RB). Several stressful growth conditions including iron deprivation halt chlamydial cell division and cause development of a morphologically enlarged, but viable form termed an aberrant body (AB). This phenotype constitutes the chlamydial developmental state known as persistence. This state is reversible as removal of the stressor allows the chlamydiae to re-enter and complete the normal developmental cycle. Bioinformatic analysis indicates that C. trachomatis encodes a homolog of Dxr, but its function and the requirement for isoprenoid synthesis in chlamydial development is not fully understood. We hypothesized that chlamydial Dxr (DxrCT) is functional and that the methylerythritol phosphate (MEP) pathway is required for normal chlamydial development. Thus, FSM exposure should be lethal to C. trachomatis. Overexpression of chlamydial Dxr (DxrCT) in Escherichia coli under FSM exposure and in a conditionally lethal dxr mutant demonstrated that DxrCT functions similarly to E. coli Dxr. When Chlamydia-infected cultures were exposed to FSM, EB production was significantly reduced. However, titer recovery assays, electron microscopy, and peptidoglycan labeling revealed that FSM inhibition of isoprenoid synthesis is not lethal to C. trachomatis, but instead induces persistence. Bactoprenol is a critical isoprenoid required for peptidoglycan precursor assembly. We therefore conclude that FSM induces persistence in Chlamydia by preventing bactoprenol production necessary for peptidoglycan precursor assembly and subsequent cell division. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS pathogens, 2019 (prima pubblicazione 2019-10-17). Identificativi: PMID 31622442 · PMCID PMC6818789 · DOI 10.1371/journal.ppat.1008078. Pagina: https://europepmc.org/article/MED/31622442 — https://doi.org/10.1371/journal.ppat.1008078. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-10T07:32:13.898Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.